文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

中重度化脓性汗腺炎患者 EQ-5D-5L 与 EQ-5D-3L 的测量性能比较。

The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa.

机构信息

Department of Health Economics, Corvinus University of Budapest, Fővám tér 8, H-1093, Budapest, Hungary.

Károly Rácz Doctoral School of Clinical Medicine, Semmelweis University, Üllői út 26, H-1085, Budapest, Hungary.

出版信息

Qual Life Res. 2021 May;30(5):1477-1490. doi: 10.1007/s11136-020-02732-x. Epub 2021 Feb 3.


DOI:10.1007/s11136-020-02732-x
PMID:33534032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8068690/
Abstract

PURPOSE: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that affects up to 1% of the population in Europe. The EQ-5D is the most commonly used generic instrument for measuring health-related quality of life among HS patients. This study aims to compare the measurement properties of the two adult versions of EQ-5D (EQ-5D-3L and EQ-5D-5L) in patients with HS. METHODS: We recruited 200 consecutive patients with HS (mean age 37 years, 38% severe or very severe HS) to participate in a multicentre cross-sectional survey. Patients completed the EQ-5D-3L, EQ-5D-5L, Dermatology Life Quality Index (DLQI) and Skindex-16 questionnaires. RESULTS: More than twice as many different health state profiles occurred in the EQ-5D-5L compared to the EQ-5D-3L (101 vs. 43). A significant reduction in ceiling effect was found for the mobility, self-care and usual activities dimensions. A good agreement was established between the EQ-5D-3L and EQ-5D-5L with an intraclass correlation coefficient of 0.872 (95% CI 0.830-0.903; p < 0.001) that was confirmed by a Bland-Altman plot. EQ-5D-5L improved both the absolute and relative informativity in all dimensions except for anxiety/depression. EQ-5D-3L and EQ-5D-5L demonstrated similar convergent validity with DLQI and Skindex-16. EQ-5D-5L was able to better discriminate between known groups of patients based on the number of comorbidities and disease severity (HS-Physician's Global Assessment). CONCLUSION: In patients with HS, the EQ-5D-5L outperformed the EQ-5D-3L in feasibility, ceiling effects, informativity and known-groups validity for many important clinical characteristics. We recommend using the EQ-5D-5L in HS patients across various settings, including clinical care, research and economic evaluations.

摘要

目的:化脓性汗腺炎(HS)是一种影响欧洲人群中高达 1%的慢性炎症性皮肤病。EQ-5D 是用于衡量 HS 患者健康相关生活质量的最常用的通用工具。本研究旨在比较 EQ-5D 的两种成人版本(EQ-5D-3L 和 EQ-5D-5L)在 HS 患者中的测量特性。

方法:我们招募了 200 名连续的 HS 患者(平均年龄 37 岁,38%为严重或非常严重的 HS)参加多中心横断面调查。患者完成了 EQ-5D-3L、EQ-5D-5L、皮肤病生活质量指数(DLQI)和 Skindex-16 问卷。

结果:EQ-5D-5L 比 EQ-5D-3L 出现的健康状态谱多了两倍以上(101 比 43)。在移动性、自我护理和日常活动维度上发现显著降低了天花板效应。EQ-5D-3L 和 EQ-5D-5L 之间建立了良好的一致性,组内相关系数为 0.872(95%置信区间 0.830-0.903;p<0.001),这通过 Bland-Altman 图得到了证实。EQ-5D-5L 在除焦虑/抑郁外的所有维度上都提高了绝对和相对信息量。EQ-5D-3L 和 EQ-5D-5L 与 DLQI 和 Skindex-16 均显示出相似的收敛效度。EQ-5D-5L 能够根据共病数量和疾病严重程度(HS-医生总体评估)更好地区分已知患者组。

结论:在 HS 患者中,EQ-5D-5L 在可行性、天花板效应、信息量和已知组有效性方面优于 EQ-5D-3L,可用于衡量 HS 患者的许多重要临床特征。我们建议在各种情况下(包括临床护理、研究和经济评估)在 HS 患者中使用 EQ-5D-5L。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/8068690/30e91b1b2e7f/11136_2020_2732_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/8068690/3e91802c4ac3/11136_2020_2732_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/8068690/30e91b1b2e7f/11136_2020_2732_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/8068690/3e91802c4ac3/11136_2020_2732_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/8068690/30e91b1b2e7f/11136_2020_2732_Fig2_HTML.jpg

相似文献

[1]
The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa.

Qual Life Res. 2021-5

[2]
Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.

J Eur Acad Dermatol Venereol. 2020-11

[3]
Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis.

Eur J Health Econ. 2023-2

[4]
Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.

Qual Life Res. 2017-12

[5]
Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.

Arch Dermatol Res. 2017-7

[6]
Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.

Qual Life Res. 2018-9-17

[7]
Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China.

Qual Life Res. 2021-7

[8]
The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.

Clin Orthop Relat Res. 2019-7

[9]
Health-related quality of life in patients with lower limb amputation - an assessment of the measurement properties of EQ-5D-3L and EQ-5D-5L using data from the Swedish Amputation and Prosthetics Registry.

Disabil Rehabil. 2022-12

[10]
Comparing the properties of the EQ-5D-5L and EQ-5D-3L in general population in Iran.

Int J Health Plann Manage. 2021-9

引用本文的文献

[1]
Comparison of health-related quality of life in atopic dermatitis, hidradenitis suppurativa, pemphigus and psoriasis.

Arch Dermatol Res. 2025-1-18

[2]
Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases.

Eur J Health Econ. 2025-6

[3]
The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality-of-life instruments: A systematic review.

J Eur Acad Dermatol Venereol. 2025-3

[4]
Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata.

Pharmacoecon Open. 2024-9

[5]
Population-level norm values by EQ-5D-3L in Hungary - a comparison of survey results from 2022 with those from 2000.

Qual Life Res. 2024-9

[6]
Measurement properties of the EQ-5D-3L, EQ-5D-5L, and SF-6Dv2 in patients with late-onset Pompe disease.

Eur J Health Econ. 2024-12

[7]
Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary.

Pharmacoeconomics. 2024-5

[8]
Societal costs and health related quality of life in adult atopic dermatitis.

BMC Health Serv Res. 2023-8-14

[9]
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe.

Patient. 2023-3

[10]
Health-Related Quality of Life and Utility Scores of Posttreatment Patients with Gastric Cancer at Different Pathological Stages: A Cross-Sectional Study.

J Oncol. 2022-4-23

本文引用的文献

[1]
Early health economic modelling for a treatment candidate in hidradenitis suppurativa.

J Med Econ. 2020-12

[2]
Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary.

Value Health. 2020-8-12

[3]
The epidemiology of hidradenitis suppurativa.

Br J Dermatol. 2020-12

[4]
Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population.

Qual Life Res. 2020-12

[5]
Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.

J Eur Acad Dermatol Venereol. 2020-11

[6]
Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System.

Dermatology. 2020

[7]
Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines.

Eur J Health Econ. 2020-11

[8]
Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life.

J Eur Acad Dermatol Venereol. 2021-1

[9]
Exploring the relation between the EQ-5D-5L pain/discomfort and pain and itching in a sample of burn patients.

Health Qual Life Outcomes. 2020-5-19

[10]
Exploring the EQ-5D Dimension of Pain/Discomfort in Dermatology Outpatients from a Multicentre Study in 13 European Countries.

Acta Derm Venereol. 2020-4-21

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索